Abstract

The purpose of this study was to develop methodology to segment tumors on 18F-fluorodeoxyg- lucose (FDG) positron emission tomography (PET) images. Sixty-four metastatic bone tumors were included. Graph cut was used for tumor segmentation, with segmentation energy divided into unary and pairwise terms. Locally connected conditional random fields (LCRF) were proposed for the pairwise term. In LCRF, three-dimensional cubic window with length L was set for each voxel, and voxels within the window were considered for the pairwise term. Three other types of segmentation were applied: region-growing based on 35%, 40%, and 45% of the tumor maximum standardized uptake value (RG35, RG40, and RG45, respectively), SLIC superpixels (SS), and region-based active contour models (AC). To validate the tumor segmentation accuracy, dice similarity coefficients (DSC) were calculated between the result of each technique and manual segmentation. Differences in DSC were tested using the Wilcoxon signed-rank test. Mean DSCs for LCRF at L = 3, 5, 7, and 9 were 0.784, 0.801, 0.809, and 0.812, respectively. Mean DSCs for the other techniques were: RG35, 0.633; RG40, 0.675; RG45, 0.689; SS, 0.709; and AC, 0.758. The DSC differences between LCRF and other techniques were statistically significant (p < 0.05). Tumor segmentation was reliably performed with LCRF.

Highlights

  • 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is widely used for the diagnosis and staging of malignant tumors

  • Representative FDG-PET image and tumor segmentation results are shown in Figure 2, which demonstrates that the bone tumor was reliably segmented using Locally connected conditional random fields (LCRF) at L = 9

  • In LCRF, the local spatial information was efficiently incorporated into the pairwise term of the segmentation energy, which led to accurate tumor segmentation

Read more

Summary

Introduction

18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is widely used for the diagnosis and staging of malignant tumors. FDG uptake has been studied thoroughly to allow its use as an imaging biomarker in oncology One such application is tumor segmentation on FDG-PET images to quantify cancer aggressiveness. Recent advances in radiation therapy have enabled the precise delivery of a high dose to the target tumor; FDG-PET is the main imaging modality allowing definition of the target tumor based on its metabolic properties [5]. For such oncological applications of FDG-PET, accurate tumor segmentation and estimation of the functional tumor volume are essential

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call